Subsidiary of ApicHope Pharmaceutical Group(300723.SZ) obtains registration certificate for Phenobarbital Tablets.
Yipinhong (300723.SZ) announced that its wholly-owned subsidiary, Guangzhou Yipinhong Pharmaceutical Co., Ltd., has recently received the "Drug Registration Certificate" approved and issued by the National Medical Products Administration for the registration of Benzbromarone tablets as a chemical drug in category 3, equivalent to passing consistency evaluation. The indication of this drug is for primary hyperuricemia and intermittent period of gouty arthritis.
ApicHope Pharmaceutical Group (300723.SZ) announced that its wholly-owned subsidiary, Guangzhou ApicHope Pharmaceutical Group Pharmaceutical Co., Ltd., recently received the "Drug Registration Certificate" issued by the National Medical Products Administration for the drug Benzbromarone tablets. The approved Benzbromarone tablets fall under category 3 chemical drugs for registration, equivalent to passing consistency evaluation. The drug is indicated for primary hyperuricemia and intermittent periods of gouty arthritis.
Related Articles
CG SERVICES (06098) spent 1.101 million Hong Kong dollars on July 23 to repurchase 200,000 shares.
New China Life Insurance (01336) has completed the issuance of a total of 10 billion yuan of perpetual capital bonds.
Shenzhen International (00152): "23 International P3" will pay interest and delist on July 27th.
CG SERVICES (06098) spent 1.101 million Hong Kong dollars on July 23 to repurchase 200,000 shares.
New China Life Insurance (01336) has completed the issuance of a total of 10 billion yuan of perpetual capital bonds.
Shenzhen International (00152): "23 International P3" will pay interest and delist on July 27th.
RECOMMEND
